Dr. Oktay is a member of the American Society for Reproductive Medicine and in 2010 received a Star Award from the society. The Award is given to those ASRM members that are nominated by their peers, who have continuously contributed 10 or more years of presentations. Dr. Oktay has had 14 presentations accepted to the American Society of Reproductive Medicine, in 2011 alone. He even has an award-winning oral abstract on improving ovarian transplantation for fertility preservation. Dr. Oktay's other accepted research include ovarian reserve, surgical techniques, and mental well-being in patients receiving fertility preservation. Congratulations Dr. Oktay on these wonderful achievements!
Dr. Kutluk Oktay to Join RS of NY:
We are pleased to announce that Dr. Kutluk Oktay, of New York Medical College in Westchester has joined our practice on April 1. Dr. Oktay is known for his ground-breaking research in fertility preservation in cancer patients. He is currently researching the causes of oocyte aging. He is an accomplished robotic surgeon and also a committee chairman for the American Society for Clinical Oncologist in the area of fertility preservation. He is also the founder of Transatlantic Reproductive Technologies Network (TARTEN). Please join us in welcoming him to our practice!
Visit his website...http://www.fertilitypreservation.org.
Dr. Kutluk Oktay preforms 1st successful robotic overian tissue transplant:
Dr. Kutluk Oktay performed the 1st successful robotic ovarian tissue transplant in a British woman who had her ovarian tissue cryopreserved 5 years ago prior to undergoing cancer chemotherapy. This opens many options for patients who wish to preserve their fertility before cancer treatment and is particularly beneficial for patients who cannot or do not choose to do IVF, such as patients with hormonally sensitive tumors or children. The patient has written an account of her experiences in www.lifeonice.org.
Read the stor y...www.dailymail.co.uk
Kutluk Oktay, M.D., F.A.C.O.G., is one of the worlds foremost experts in fertility preservation as well as ovarian stimulation and in vitro fertilization for infertility treatments. He developed and performed the world's first ovarian transplantation procedures as well as pioneered new ovarian stimulation protocols for embryo and oocyte freezing for breast and endometrial cancer patients. Dr. Oktay conducted key research on ovarian follicle and embryo development, as well as on controlled ovarian stimulation and in vitro fertilization. Dr. Oktay has devoted his professional life to the science of fertility preservation and infertility treatment. He is a world-renowned researcher, a gifted medical educator, and a skilled clinician dedicated to his patients. Dr. Oktay was invited to the President's Cancer Panel as an expert on fertility issues of cancer patients and fertility preservation. In attestation to his recognition as a leading clinician-scientist in infertility field, he received a highly competitive multi- million-dollar research grant from the National Institute of Health to study the impact of chemotherapy on fertility of cancer survivors. Furthermore, he was named the co-chair of the American Society of Clinical Oncology Committee for Fertility Preservation Guideline for People with Cancer. He founded and was elected as the first President of the Fertility Preservation Special Interest Group at American Society of Reproductive Medicine. In 2008, after a 10-year career at the Weill Medical College of Cornell University, Dr. Oktay became a Professor of Obstetrics & Gynecology and the Director of Division of Reproductive Medicine & Infertility at New York Medical College/Westchester Medical Center and founded the Center for Reproductive Medicine and Institute for Fertility Preservation (CRM-IFP). He also was named a Consultant Physician at Memorial Sloan-Kettering Cancer Center, and a Consultant for Cancer and Allied Diseases at Memorial Hospital. | 
